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Abstract
Background: Multi-drug-resistant Mycobacterium tuberculosis has been an important problem in public health
around the world. However, limited information about disinfectant-susceptibility of multi-drug-resistant strain of M.
tuberculosis was available.
Findings: We studied susceptibility of several Japanese isolates of multi-drug-resistant M. tuberculosis against
disinfectants, which are commonly used in clinical and research laboratories. We selected a laboratory reference
strain (H37Rv) and eight Japanese isolates, containing five drug-susceptible strains and three multi-drug-resistant
strains, and determined profiles of susceptibility against eight disinfectants. The M. tuberculosis strains were
distinguished into two groups by the susceptibility profile. There was no relationship between multi-drug-resistance
and disinfectant-susceptibility in the M. tuberculosis strains. Cresol soap and oxydol were effective against all strains
we tested, regardless of drug resistance.
Conclusions: Disinfectant-resistance is independent from multi-drug-resistance in M. tuberculosis. Cresol soap and
oxydol were effective against all strains we tested, regardless of drug resistance.
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Findings
Tuberculosis is still a major cause of death in low to
middle-income countries and areas [1]. Furthermore,
drug resistant and multi-drug-resistant tuberculosis
has been reported worldwide [2]. Tuberculosis has
remained as a major public health threat even in this
century [1, 2].
Disinfectants are widely used to eliminate infectious
agents from possibly contaminated equipment and spec-
imens. Effectiveness of disinfectants against M. tubercu-
losis was reported previously [3–5]. However, poor
information about disinfectant effectiveness against
multi-drug-resistant (MDR) strain of M. tuberculosis is
available. In this study, we first evaluated effectiveness of
disinfectants against MDR-M. tuberculosis in just short
time (1-min), on the supposition that the disinfectants
were used for routine environmental cleaning by spray,
wipe, or wash in relatively short time to M. tuberculosis.
Then we discussed relationship between drug resistance
and disinfectant resistance in M. tuberculosis.
M. tuberculosis strains used in this study are listed in
Table 1. M. tuberculosis strain H37Rv is the reference
strain isolated in US in 1934. Other eight strains were
fresh clinical isolates from Japanese patients. The strains
were cultured in Middlebrook 7H9 broth (BD Biosci-
ences, Sparks, MD) supplemented with 10 % OADC En-
richment (BD Biosciences) and 0.05 % (w/v) Tween 80
(this medium was referred as MB broth).
We selected commonly used and easily available eight
disinfectants, including 0.2 % (W/V) alkyldiaminoethyl-
glycine-HCl (ADEG), 0.1 % (W/V) chlorhexidine gluco-
nate (CG), 10 mg/ml povidine iodine (PI), 0.1 % (W/V)
benzalkonium-HCl (BK), 3 % (W/V) oxydol (OX), 2 %
(V/V) cresol soap (CS), 70 % (V/V) ethanol (EtOH), and
0.1 % (W/V) benzalkonium-HCl + 70 % (V/V) ethanol
(BK + EtOH). The disinfectants were diluted with
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distilled water according to the instructions of the man-
ufacturers. M. tuberculosis strains were cultured in MB
broth for 14 days at 37 °C. Optical density at 650 nm
(OD650) of each bacterial culture was adjusted to 1.0.
The adjusted bacterial culture was diluted to 0.1 of
OD650 with fresh MB broth, and then its 100 μl was
added into 1 ml of diluted disinfectant in a sterilized
tube with screw cap. After 30 s incubation at room
temperature, the tube was centrifuged for 30 s at 9600 ×
g at room temperature and the supernatants were re-
moved. The pellet was immediately resuspended in 1 ml
of fresh MB broth, and then the suspension was cultured
for 14 days at 37 °C. The 14 days culture was sufficient
to detect growth of M. tuberculosis by the real time
qPCR described below. The tubes were centrifuged
(16,200 × g, 2 min, room temperature) to collect bacter-
ial cells. Then the cells were suspended in solution con-
taining 20 μl of 0.5 M NaOH, 4 μl of 10 % sodium
dodecyl sulfate, and 180 μl of distilled water. The sus-
pension was heated at 95 °C for 15 min, and then cooled
to room temperature. Two hundred microliters of phe-
nol/chloroform (1:1) was added and then mixed
strongly. After centrifugation at 16,200 × g for 5 min, its
aqueous phase was transferred into a new tube, and this
step was repeated twice. The aqueous phase was added
with 16 μl of 5 M NaCl and 800 μl of 70 % ethanol, and
then centrifuged at 16,200 × g for 1 min. The pellet
(purified total DNA) was resuspended in 50 μl of dis-
tilled water.
Bacterial growth was measured 16S rRNA gene-targeted
real-time quantitative PCR (qPCR) with the 16S rRNA-TF
primer (5′-ACGGAAAGGTCTCTTCG-3′) and 16S
rRNA-TR primer (5′- GTCGTCGCCTTGGTAG-3′) [6].
The PCR was performed by using KAPA SYBR FAST
qPCR Master Mix (2×) Universal (NIPPON Genetics,
Tokyo, Japan) according to the manufacture’s instruction.
Real-time qPCR was performed using the following cyc-
ling conditions: 1 cycle of 95 °C for 30 s, 40 cycles of 95 °C
for 5 s and 60 °C for 30 s, a final extension of 60 °C for 5 s
and a melting curve of 60 °C to 95 °C.
Efficacy of disinfectant was evaluated by growth inhib-
ition of the bacteria. Disinfectants were judged as not ef-
fective when the copy number of 16S rRNA gene would
be significantly increased by culture. One-way ANOVA
with Dunnett’s test was used for the statistical analysis.
M. tuberculosis strain H37Rv, which is a widely used
laboratory strain, was susceptible to all the disinfectants
we tested. Since the strain was isolated in 1934 [7], it
could be adapted to laboratory propagations. The strain
might lose resistance against bactericidal compounds.
We found that there were two groups in the Japanese
isolates of M. tuberculosis based on susceptibility against
disinfectants. Strain 2E-1-9, 2U-11-2, LV-15, and LV-79
were susceptible to most disinfectants used in this study,
whereas the strain 2A-3-6, 2U-5-12, 2Z-1-3, and LV-36
showed resistance against most disinfectants except oxy-
dol and cresol soap (Fig. 1, Table 1). There was no rela-
tionship between multi-drug-resistance and disinfectant-
resistance in the selected M. tuberculosis strains. The
tick and waxy cell wall of M. tuberculosis is assumed to
act as a major barrier to penetration of antibiotics and
disinfectants [8], and could affect to resistance against
both antibiotics and disinfectants. Since there was no
correlation between drug resistance and disinfectant re-
sistance to the M. tuberculosis strains in this study, the
drug resistance and the disinfectant resistance might be
based on different mechanism in the strains.
Oxydol and cresol soap were effective against all M.
tuberculosis strains tested in this study, even MDR
strains. Our results suggested that more than 1 min
Table 1 M. tuberculosis strains used in this study
Strain Place Year Multidrug resistance Disinfectant
ADEG CG PI BK OX CS EtOH BK + EtOH
H37Rv US 1934 Type strain + + + + + + + +
2A-3-6 Japan 2002 – – – – – + + – –
2E-1-9 Japan 2002 – + + + + + + – –
2U-5-12 Japan 2002 – – – + – + + – –
2U-11-2 Japan 2002 – + + + + + + + –
2Z-1-3 Japan 2002 – + – – – + + – –
LV-15 Japan 2008 INH, RFP, SM, EB, LVFX – + + + + + – –
LV-36 Japan 2010 INH, RFP, SM – – – – + + – +
LV-79 Japan 2009 INH, RFP, SM, LVFX + + + + + + + +
INH, isoniazid; RFP, rifampicin; SM, streptomycin; EB, ethambutol; and LVFX, levofloxacin, ADEG alkyldiaminoethylglycine-HCl (0.2 % W/V); CG chlorhexidine gluco-
nate (0.1 % W/V); PI, povidine iodine (10 mg/ml as active iodine); BK benzalkonium-HCl (0.1 % W/V); OX oxydol (3 % W/V); CS cresol soap (2 % V/V); EtOH ethanol
(70 % V/V); and BK + EtOH benzalkonium-HCl (0.1 % W/V) + ethanol (70 % V/V)
+: the disinfectant inhibited growth of the bacteria (effective disinfectants)
−: the disinfectant did not inhibit growth of the bacteria (not effective)
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treatments with oxydol or cresol soap were promis-
ing to eliminate contamination of M. tuberculosis,
regardless of drug resistance. However, it is known
that disinfectants could decrease their efficacy by or-
ganic compounds, for example, blood, sputum, and
other dirt. It should be noticed that disinfectant
could be used carefully against M. tuberculosis in
clinical specimens and things that contain organic
compounds.
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Fig. 1 Efficacy of disinfectants to M. tuberculosis stains. Each M. tuberculosis stain was exposed to the disinfectants for 1 min at room temperature.
The bacteria were incubated in Middlebrook 7H9 broth for 14 days at 37 °C. Bacterial growth was measured by 16S rRNA targeted real-time qPCR.
Control was not exposure by any disinfectants. Dashed line indicates the genome copy number on the day of inoculation. ADEG,
alkyldiaminoethylglycine-HCl (0.2 % W/V); CG, chlorhexidine gluconate (0.1 % W/V); PI, povidine iodine (10 mg/ml as active iodine); BK,
benzalkonium-HCl (0.1 % W/V); OX, oxydol (3 % W/V); CS, cresol soap (2 % V/V); EtOH, ethanol (70 % V/V); and BK + EtOH, benzalkonium-HCl
(0.1 % W/V) + ethanol (70 % V/V). The results are expressed as means ± SD. *: p <0.05 (v.s. genome number on the day of inoculation). Black bars:
the disinfectant inhibited growth of M. tuberculosis (effective disinfectant). White bars: the disinfectant did not inhibit growth of the bacteria
(not effective)
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